NaviFUS Corp. (6872.TWO)
TWD 23.35
(-9.85%)
TWD 23.35
(-9.85%)
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2023 | -55.79 Million TWD | -10.17% |
| 2022 | -53.84 Million TWD | 30.76% |
| 2021 | -73.14 Million TWD | -38.24% |
| 2020 | -52.45 Million TWD | -6.05% |
| 2019 | -49.88 Million TWD | 0.0% |
| Year | EBITDA | EBITDA Growth |
|---|---|---|
| 2024 Q1 | -17.41 Million TWD | 38.89% |
| 2024 Q2 | -22 Million TWD | -26.38% |
| 2023 Q1 | -9.8 Million TWD | 0.0% |
| 2023 FY | - TWD | -10.17% |
| 2023 Q2 | -2.94 Million TWD | 69.93% |
| 2022 FY | - TWD | 30.76% |
| 2021 FY | - TWD | -38.24% |
| 2020 FY | - TWD | 0.0% |
| Name | EBITDA | EBITDA Difference |
|---|---|---|
| Anti-Microbial Savior BioteQ Co., Ltd | -46.24 Million TWD | -20.653% |
| SYN-TECH Chem. & Pharm. Co., Ltd. | 393.6 Million TWD | 114.175% |
| Level Biotechnology Inc. | 98.7 Million TWD | 156.528% |
| Sagittarius Life Science Corp | -44.73 Million TWD | -24.712% |
| NeoCore Technology Co., Ltd. | -72.11 Million TWD | 22.631% |
| TaiMed Biologics Inc. | -25.23 Million TWD | -121.119% |
| GlycoNex Incorporation | -126.82 Million TWD | 56.007% |
| VBI | -6.97 Million TWD | -700.273% |
| GeneReach Biotechnology Corp. | -143.69 Million TWD | 61.171% |
| Taiwan Advance Bio-Pharmaceutical Inc. | 21.81 Million TWD | 355.823% |
| SynCore Biotechnology Co.,Ltd | -17.72 Million TWD | -214.764% |
| Genomics BioSci & Tech. Co.,Ltd. | -103.61 Million TWD | 46.152% |
| Visgeneer Inc. | 973 Thousand TWD | 5834.327% |
| Mycenax Biotech Inc. | -339.48 Million TWD | 83.565% |
| Sunmax Biotechnology Co., Ltd. | 936.46 Million TWD | 105.958% |
| G&E Herbal Biotechnology Co., Ltd. | 99.83 Million TWD | 155.886% |
| Neith Corporation | -33.61 Million TWD | -66.007% |
| Medigen Vaccine Biologics Corporation | -991.09 Million TWD | 94.37% |
| TaiwanJ Pharmaceuticals Co., Ltd. | -1.73 Million TWD | -3112.147% |
| Enimmune corporation | -228.96 Million TWD | 75.631% |
| TaiRx, Inc. | -208.64 Million TWD | 73.259% |
| CHO Pharma, Inc. | -277.73 Million TWD | 79.91% |
| EirGenix Inc. | -664.4 Million TWD | 91.602% |
| BioLASCO Taiwan Co., Ltd. | 73.9 Million TWD | 175.497% |
| Sunny Pharmtech Inc. | 69.14 Million TWD | 180.695% |
| Lin BioScience, Inc. | -1.07 Billion TWD | 94.792% |
| BioGend Therapeutics Co., Ltd. | -113.1 Million TWD | 50.67% |
| Feng Chi Biotech Corp. | 34.83 Million TWD | 260.156% |
| Bio Preventive Medicine Corp. | -62.34 Million TWD | 10.5% |
| Lukas Biomedical Inc. | -26.3 Million TWD | -112.148% |
| RBC Bioscience Corporation | 36.54 Million TWD | 252.666% |
| BiOptic Inc. | 65.03 Million TWD | 185.788% |
| BRIM Biotechnology, Inc. | -682.46 Million TWD | 91.824% |
| Shine-On BioMedical Co.,Ltd. | -33 Million TWD | -69.045% |
| Great Novel Therapeutics Biotech & Medicals | -54.91 Million TWD | -1.602% |
| Syngen Biotech Co.,Ltd. | 433.55 Million TWD | 112.869% |
| Advagene Biopharma Co., Ltd. | -80.07 Million TWD | 30.319% |
| Gwo Xi Stem Cell Applied Technology Co. , Ltd | -16.59 Million TWD | -236.155% |
| Sinew Pharma Inc. | -163.63 Million TWD | 65.902% |
| Andros Pharmaceuticals Co.,Ltd | -61.5 Million TWD | 9.276% |
| Greenyn Biotechnology Co., Ltd | 192.4 Million TWD | 128.999% |
| Lumosa Therapeutics Co., Ltd. | -226.67 Million TWD | 75.386% |
| AP Biosciences Inc | -325.51 Million TWD | 82.859% |
| Medigen Biotechnology Corp. | -1.04 Billion TWD | 94.659% |
| 3D Global Biotech Inc. | -35.84 Million TWD | -55.652% |
| Pharmosa Biopharm Inc. | 29.13 Million TWD | 291.538% |
| Intech Biopharm Corporation | -219.58 Million TWD | 74.591% |
| Oneness Biotech Co., Ltd. | -674.22 Million TWD | 91.725% |
| Eusol Biotech Co.,Ltd. | -44.95 Million TWD | -24.124% |
| TWi Biotechnology, Inc. | -160.85 Million TWD | 65.314% |
| Ever Supreme Bio Technology Co., Ltd | 655.52 Million TWD | 108.512% |
| TCI GENE Inc. | 25.98 Million TWD | 314.753% |
| MegaPro Biomedical Co., Ltd | -110.63 Million TWD | 49.57% |
| Senhwa Biosciences, Inc. | -283.78 Million TWD | 80.339% |
| Taiwan Bio Therapeutics Co., Ltd | -145.97 Million TWD | 61.776% |
| NatureWise Biotech & Medicals Corporation | 13.85 Million TWD | 502.852% |
| PharmaEngine, Inc. | 347.3 Million TWD | 116.065% |
| Savior Lifetec Corporation | 219.6 Million TWD | 125.407% |
| TaiGen Biopharmaceuticals Holdings Limited | 172.23 Million TWD | 132.396% |
| OBI Pharma, Inc. | -855.08 Million TWD | 93.475% |
| Meribank Biotech Co., Ltd | -92.56 Million TWD | 39.722% |
| Acepodia, Inc. | -764.51 Million TWD | 92.702% |
| Caliway Biopharmaceuticals Co., Ltd. | -460.09 Million TWD | 87.873% |